Skip to main navigation Skip to search Skip to main content

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

  • VX18-121-101
  • , VX18-561-101 Study Groups

Research output: Contribution to journal › Article › peer-review

73   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science